Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy

Authors:

Abstract
No abstract available
Funding Information
  • Actelion Pharmaceuticals Ltd. (Switzerland)
  • Encysive Pharmaceuticals Inc. (Houston, USA)

This publication has 55 references indexed in Scilit: